HYPERION DEFI INC (HYPD)
NASDAQHealth CareAsset Management - CryptocurrencySnapshot 2026-09-04
$3.300.00%
Close 2026-09-04 · 1-day change
NASDAQHealth CareAsset Management - CryptocurrencySnapshot 2026-09-04
QuarterlyIQ Insights · HYPD
Income statement, balance sheet, and cash flow — annual and quarterly history, as reported.
Figures in millions of None, except per-share and ratios.
| TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | FY 2019 | FY 2018 | FY 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | ||||||||||
| Revenues | — | 0.8 | 0.1 | 0.0 | — | 14.0 | 2.0 | — | — | — |
| Cost of Revenues | — | 0.3 | 3.9 | 0.0 | — | 1.6 | 0.8 | — | — | — |
| Gross Profit | — | 0.5 | (3.9) | (0.0) | — | 12.4 | 1.2 | — | — | — |
| Operating Expenses & Income | ||||||||||
| Selling, General & Admin | 15.5 | 17.2 | 14.3 | 12.4 | — | — | — | — | — | — |
| R&D Expenses | 0.9 | 1.9 | 14.5 | 13.0 | 13.4 | 14.9 | 13.4 | 14.1 | 11.1 | 3.8 |
| Operating Income | — | (46.7) | (48.7) | (25.4) | (26.9) | (13.0) | (19.8) | (21.3) | (17.3) | (5.1) |
| Earnings from Continuing Operations | ||||||||||
| Interest Expense | — | 1.6 | 2.5 | 2.4 | 1.4 | 0.4 | 0.0 | — | — | — |
| Interest & Investment Income | 0.6 | 0.2 | 0.3 | 0.7 | — | — | — | — | — | 0.0 |
| Net Interest Expenses | — | — | — | 1.7 | — | — | — | — | — | — |
| Other Non-Operating Income / Expenses | 2.2 | 1.4 | (1.1) | (1.9) | (1.1) | — | — | — | — | — |
| Asset Writedown | — | — | 11.2 | — | — | — | — | — | — | — |
| Income Tax Expense | — | (0.0) | — | — | — | — | — | 0.0 | 0.0 | 0.0 |
| Net Income | ||||||||||
| Net Income | 6.7 | (45.3) | (49.8) | (27.3) | (28.0) | (12.8) | (19.8) | (21.2) | (17.3) | (5.1) |
| Per Share | ||||||||||
| Basic EPS | 0.47 | (9.40) | (59.81) | (53.15) | (0.83) | (0.49) | (0.94) | — | — | — |
| Diluted EPS | 0.39 | (9.40) | (59.81) | (53.15) | (0.83) | (0.49) | (0.94) | — | — | — |
| Basic Weighted Avg Shares | 14.2 | 5.0 | 0.8 | 0.5 | 33.6 | 26.3 | 21.1 | — | — | — |
| Diluted Weighted Avg Shares | 17.0 | 5.0 | 0.8 | 0.5 | 33.6 | 26.3 | 21.1 | — | — | — |
| Supplemental | ||||||||||
| EBITDA | — | — | (47.6) | (24.6) | (26.6) | (12.8) | (19.7) | (21.3) | (17.2) | (5.1) |
| EBIT | — | (46.7) | (48.7) | (25.4) | (26.9) | (13.0) | (19.8) | (21.3) | (17.3) | (5.1) |
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.